Department of Pharmacy, Tianjin First Central Hospital, Tianjin, PR China.
Pharm Biol. 2011 Nov;49(11):1144-9. doi: 10.3109/13880209.2011.574707. Epub 2011 Apr 26.
CONTEXT: Diabetes mellitus is characterized by oxidative stress, which in turn induces endothelial dysfunction. As a potent antioxidant compound, lycopene might rescue diabetic endothelial dysfunction by reducing oxidative stress. OBJECTIVE: The present study investigated whether lycopene could lower oxidative stress and attenuate endothelial dysfunction in diabetic rats. METHODS: Different doses of lycopene (10, 30, and 60 mg/kg/day, p.o.) were administered for 30 days to streptozotocin (STZ) (60 mg/kg)-induced diabetic rats. Biochemical parameters and aortic malondialdehyde (MDA) content, superoxidase dismutase (SOD) activity, nitric oxide (NO) levels, constitutive NOS (cNOS) activity, and inducible NOS (iNOS) activity were determined. Endothelium-dependent and endothelium-independent vasorelaxation were measured in aortas for estimating endothelial function. RESULTS: Compared with normal controls, endothelial function was significantly reduced in diabetic rats and the blunted endothelial function was dependently ameliorated with lycopene treatment. Compared with normal controls, the serum oxidized low-density lipoprotein (ox-LDL) levels, the aortic MDA levels, and iNOS activity in diabetic rats were increased by 113, 197, and 100%, respectively, whereas aortic SOD activity, NO levels, and cNOS activity were decreased by 73, 53, and 65%, respectively. Exogenous administration of lycopene to diabetic rats caused a dose-dependent decrease of serum glucose and ox-LDL levels, an increase of aortic SOD activity, NO levels, and cNOS activity, and a decrease of aortic MDA levels and iNOS activity. CONCLUSION: Chronic lycopene treatment could attenuate endothelial dysfunction by reducing oxidative stress in STZ-induced diabetic rats. These results indicate that chronic lycopene treatment might be useful in preventing diabetic vascular complications associated with endothelial dysfunction.
背景:糖尿病的特征是氧化应激,而氧化应激又会导致内皮功能障碍。番茄红素作为一种有效的抗氧化化合物,通过降低氧化应激,可能会挽救糖尿病引起的内皮功能障碍。
目的:本研究旨在探讨番茄红素是否可以降低糖尿病大鼠的氧化应激并减轻其内皮功能障碍。
方法:给予不同剂量的番茄红素(10、30 和 60mg/kg/天,口服)30 天,以治疗链脲佐菌素(STZ)(60mg/kg)诱导的糖尿病大鼠。测定生化参数和主动脉丙二醛(MDA)含量、超氧化物歧化酶(SOD)活性、一氧化氮(NO)水平、结构型一氧化氮合酶(cNOS)活性和诱导型一氧化氮合酶(iNOS)活性。通过测量主动脉的内皮依赖性和非依赖性血管舒张来评估内皮功能。
结果:与正常对照组相比,糖尿病大鼠的内皮功能明显降低,而番茄红素治疗可显著改善内皮功能障碍。与正常对照组相比,糖尿病大鼠的血清氧化型低密度脂蛋白(ox-LDL)水平、主动脉 MDA 水平和 iNOS 活性分别增加了 113%、197%和 100%,而主动脉 SOD 活性、NO 水平和 cNOS 活性分别降低了 73%、53%和 65%。向糖尿病大鼠外源性给予番茄红素可剂量依赖性地降低血清葡萄糖和 ox-LDL 水平,增加主动脉 SOD 活性、NO 水平和 cNOS 活性,并降低主动脉 MDA 水平和 iNOS 活性。
结论:慢性番茄红素治疗可通过降低 STZ 诱导的糖尿病大鼠的氧化应激来减轻内皮功能障碍。这些结果表明,慢性番茄红素治疗可能有助于预防与内皮功能障碍相关的糖尿病血管并发症。
Vascul Pharmacol. 2006-12
Life Sci. 2008-7-18
Eur J Pharmacol. 2005-3-21
J Diabetes Metab Disord. 2025-1-25
Nutrients. 2024-10-30
Antioxidants (Basel). 2022-2-21
Evid Based Complement Alternat Med. 2020-10-7